The Immune Response to Mitochondrial Autoantigens

 

 Buy Article Permissions and Reprints

ABSTRACT

Similar to other autoimmune diseases, there are intense humoral and cellular responses to intracytoplasmic antigens in primary biliary cirrhosis (PBC). The autoantigens against antimitochondrial antibodies (AMAs) in PBC are located on the inner mitochondrial membrane and are identified as members of the 2-oxo-acid dehydrogenase complexes (2-OADCs), of which the E2 subunit of pyruvate dehydrogenase complex (PDC-E2) is the major autoantigen; AMAs are is present in approximately 90 to 95% of PBC sera. An orchestrated immune response against the intrahepatic biliary epithelial cell (BEC) through 2-OADC-specific CD4⁺ helper T cells and CD8⁺ CTL are thought to be the major players in the immunological destruction of BECs in PBC. We believe that a prior/primary event of specific intrahepatic BEC malfunction (possibly caused by environmental insults such as xenobiotics and microorganisms) is responsible for the breaking of self-tolerance to 2-OADC and leads to BEC destruction. The generation of 2-OADC-specific T cells further accelerates the damage of BEC. In addition, immunoglobulin A AMAs may participate in the destruction of BECs by damaging mitochondria.

REFERENCES

• 1 Kaplan M M. Primary biliary cirrhosis.  N Engl J Med. 1996;  335 1570-1580
  CrossrefPubMedGoogle Scholar
• 2 Metcalf J V, Mitchison H C, Palmer J M et al.. Natural history of early primary biliary cirrhosis.  Lancet. 1996;  348 1399-1402
  CrossrefPubMedGoogle Scholar
• 3 Gershwin M E, Mackay I R, Sturgess A et al.. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis.  J Immunol. 1987;  138 3525-3531
  PubMedGoogle Scholar
• 4 Coppel R L, McNeilage L J, Surh C D et al.. Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis: dihydrolipoamide acetyltransferase.  Proc Natl Acad Sci USA. 1988;  85 7317-7321
  PubMedGoogle Scholar
• 5 Van de Water J, Gershwin M E, Leung P et al.. The autoepitope of the 74-kDa mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase.  J Exp Med. 1988;  167 1791-1799
  CrossrefPubMedGoogle Scholar
• 6 Gajdusek D C. An auto-immune reaction against human tissue antigens in certain chronic diseases.  Nature. 1957;  179 666-668
  PubMedGoogle Scholar
• 7 Mackay I R. Primary biliary cirrhosis showing a high titer of autoantibody; report of a case.  N Engl J Med. 1958;  258 185-188
  PubMedGoogle Scholar
• 8 Walker J G, Doniach D, Roitt I M et al.. Serological tests in diagnosis of primary biliary cirrhosis.  Lancet. 1965;  39 827-831
  PubMedGoogle Scholar
• 9 Yeaman S J, Fussey S P, Danner D J et al.. Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens.  Lancet. 1988;  1 1067-1070
  PubMedGoogle Scholar
• 10 Mackay I R, Gershwin M E. Molecular basis of mitochondrial autoreactivity in primary biliary cirrhosis.  Immunol Today. 1989;  10 315-318
  CrossrefPubMedGoogle Scholar
• 11 Van de Water J, Fregeau D, Davis P et al.. Autoantibodies of primary biliary cirrhosis recognize dihydrolipoamide acetyltransferase and inhibit enzyme function.  J Immunol. 1988;  141 2321-2324
  PubMedGoogle Scholar
• 12 Matsui M, Nakamura M, Ishibashi H et al.. Human monoclonal antibodies from a patient with primary biliary cirrhosis that recognize two distinct autoepitopes in the E2 component of the pyruvate dehydrogenase complex.  Hepatology. 1993;  18 1069-1077
  CrossrefPubMedGoogle Scholar
• 13 Surh C D, Coppel R, Gershwin M E. Structural requirement for autoreactivity on human pyruvate dehydrogenase-E2, the major autoantigen of primary biliary cirrhosis. Implication for a conformational autoepitope.  J Immunol. 1990;  144 3367-3374
  PubMedGoogle Scholar
• 14 Leung P S, Chuang D T, Wynn R M et al.. Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope.  Hepatology. 1995;  22 505-513
  CrossrefPubMedGoogle Scholar
• 15 Moteki S, Leung P S, Dickson E R et al.. Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex.  Hepatology. 1996;  23 436-444
  CrossrefPubMedGoogle Scholar
• 16 Migliaccio C, Van de Water J, Ansari A A et al.. Heterogeneous response of antimitochondrial autoantibodies and bile duct apical staining monoclonal antibodies to pyruvate dehydrogenase complex E2: the molecule versus the mimic.  Hepatology. 2001;  33 792-801
  CrossrefPubMedGoogle Scholar
• 17 Bruggraber S FA, Leung P SC, Amano K et al.. Autoreactivity to lipoate and a conjugated form of lipoate as hapten and hapten/carrier in primary biliary cirrhosis.  Gastroenterology. 2003;  125 1705-1713
  CrossrefPubMedGoogle Scholar
• 18 Koike K, Ishibashi H, Koike M. Immunoreactivity of porcine heart dihydrolipoamide acetyl- and succinyl-transferases (PDC-E2, OGDC-E2) with primary biliary cirrhosis sera: characterization of the autoantigenic region and effects of enzymatic delipoylation and relipoylation.  Hepatology. 1998;  276 1467-1474
  PubMedGoogle Scholar
• 19 Howard M J, Fuller C, Broadhurst R W et al.. Three-dimensional structure of the major autoantigen in primary biliary cirrhosis.  Gastroenterology. 1998;  115 139-146
  PubMedGoogle Scholar
• 20 Van de Water J, Ansari A, Prindiville T et al.. Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis.  J Exp Med. 1995;  181 723-733
  CrossrefPubMedGoogle Scholar
• 21 Shimoda S, Nakamura M, Ishibashi H et al.. HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases.  J Exp Med. 1995;  181 1835-1845
  CrossrefPubMedGoogle Scholar
• 22 Shimoda S, Van de Water J, Ansari A et al.. Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis.  J Clin Invest. 1998;  102 1831-1840
  CrossrefPubMedGoogle Scholar
• 23 Shimoda S, Nakamura M, Ishibashi H et al.. Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis.  Gastroenterology. 2003;  124 1915-1925
  CrossrefPubMedGoogle Scholar
• 24 Moebius U, Manns M, Hess G et al.. T cell receptor gene rearrangements of T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis (PBC): oligoclonality of PBC-derived T cell clones.  Eur J Immunol. 1990;  20 889-896
  PubMedGoogle Scholar
• 25 Tsai S L, Lai M Y, Chen D S. Analysis of rearranged T cell receptor (TCR) Vb transcripts in livers of primary biliary cirrhosis: preferential Vb usage suggests antigen-driven selection.  Clin Exp Immunol. 1996;  103 99-104
  CrossrefPubMedGoogle Scholar
• 26 Ichiki Y, Shimoda S, Hara H et al.. Analysis of T-cell receptor beta of the T-cell clones reactive to the human PDC-E2 163-176 peptide in the context of HLA-DR53 in patients with primary biliary cirrhosis.  Hepatology. 1997;  26 728-733
  PubMedGoogle Scholar
• 27 Meuer S C, Moebius U, Manns M M et al.. Clonal analysis of human T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis.  Eur J Immunol. 1988;  18 1447-1452
  PubMedGoogle Scholar
• 28 Kita H, Lian Z X, Van de Water J et al.. Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells.  J Exp Med. 2002;  195 113-123
  CrossrefPubMedGoogle Scholar
• 29 Kita H, Matsumura S, He X S et al.. Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis.  J Clin Invest. 2002;  109 1231-1240
  CrossrefPubMedGoogle Scholar
• 30 Matsumura S, Kita H, He X S et al.. Comprehensive mapping of HLA-A0201-restricted CD8 T-cell epitopes on PDC-E2 in primary biliary cirrhosis.  Hepatology. 2002;  36 1125-1134
  CrossrefPubMedGoogle Scholar
• 31 Parikh-Patel A, Gold E B, Worman H et al.. Risk factors for primary biliary cirrhosis in a cohort of patients from the United States.  Hepatology. 2001;  33 16-21
  CrossrefPubMedGoogle Scholar
• 32 Burroughs A K, Butler P, Sternberg M J et al.. Molecular mimicry in liver disease.  Nature. 1992;  358 377-378
  CrossrefPubMedGoogle Scholar
• 33 Shimoda S, Nakamura M, Shigematsu H et al.. Mimicry peptides of human PDC-E2 163-176 peptide, the immunodominant T-cell epitope of primary biliary cirrhosis.  Hepatology. 2000;  31 1212-1216
  CrossrefPubMedGoogle Scholar
• 34 Tanimoto H, Shimoda S, Nakamura M et al.. Promiscuous T cells selected by Escherichia coli: OGDC-E2 in primary biliary cirrhosis.  J Autoimmun. 2003;  20 255-263
  CrossrefPubMedGoogle Scholar
• 35 Selmi C, Balkwill D L, Invernizzi P et al.. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium.  Hepatology. 2003;  38 1250-1257
  CrossrefPubMedGoogle Scholar
• 36 Kita H, Matsumura S, He X S et al.. Analysis of TCR antagonism and molecular mimicry of an HLA-A0201-restricted CTL epitope in primary biliary cirrhosis.  Hepatology. 2002;  36 918-926
  CrossrefPubMedGoogle Scholar
• 37 Tsuneyama K, Van de Water J, Leung P S et al.. Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression.  Hepatology. 1995;  21 1031-1037
  CrossrefPubMedGoogle Scholar
• 38 Harada K, Sudo Y, Kono N et al.. In situ nucleic acid detection of PDC-E2, BCOADC-E2, OGDC-E2, PDC-E1alpha, BCOADC-E1alpha, OGDC-E1, and the E3 binding protein (protein X) in primary biliary cirrhosis.  Hepatology. 1999;  30 36-45
  CrossrefPubMedGoogle Scholar
• 39 Danpure C J. The molecular basis of alanine: glyoxylate aminotransferase mistargeting: the most common single cause of primary hyperoxaluria type 1.  J Nephrol. 1998;  11(suppl 1) 8-12
  PubMedGoogle Scholar
• 40 Nathanson M H, Boyer J L. Mechanisms and regulation of bile secretion.  Hepatology. 1991;  14 551-566
  CrossrefPubMedGoogle Scholar
• 41 Davis P A, Leung P, Manns M et al.. M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: epitopes or epiphenomena?.  Hepatology. 1992;  16 1128-1136
  CrossrefPubMedGoogle Scholar
• 42 Giffroy D, Courtoy P J, Vaerman J P. Polymeric IgA binding to the human pIgR elicits intracellular signalling, but fails to stimulate pIgR-transcytosis.  Scand J Immunol. 2001;  53 56-64
  CrossrefPubMedGoogle Scholar
• 43 Brown W R, Kloppel T M. The liver and IgA: immunological, cell biological and clinical implications.  Hepatology. 1989;  9 763-784
  CrossrefPubMedGoogle Scholar
• 44 Bomsel M, Heyman M, Hocini H et al.. Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM.  Immunity. 1998;  9 277-287
  CrossrefPubMedGoogle Scholar
• 45 Koscec M, Koren E, Wolfson-Reichlin M et al.. Autoantibodies to ribosomal P proteins penetrate into live hepatocytes and cause cellular dysfunction in culture.  J Immunol. 1997;  159 2033-2041
  PubMedGoogle Scholar
• 46 Yanase K, Smith R M, Puccetti A et al.. Receptor-mediated cellular entry of nuclear localizing anti-DNA antibodies via myosin 1.  J Clin Invest. 1997;  100 25-31
  PubMedGoogle Scholar
• 47 Song W, Vaerman J P, Mostov K E et al.. Dimeric and tetrameric IgA are transcytosed equally by the polymeric Ig receptor.  J Immunol. 1995;  155 715-721
  PubMedGoogle Scholar
• 48 Malmborg A C, Shultz D B, Luton F et al.. Penetration and co-localization in MDCK cell mitochondria of IgA derived from patients with primary biliary cirrhosis.  J Autoimmun. 1998;  11 573-580
  CrossrefPubMedGoogle Scholar
• 49 Fukushima N, Nalbandian G, Van De Water J et al.. Characterization of recombinant monoclonal IgA anti-PDC-E2 autoantibodies derived from patients with PBC.  Hepatology. 2002;  36 1383-1392
  CrossrefPubMedGoogle Scholar
• 50 Tsuneyama K, Van de Water J, Leung P S et al.. Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression.  Hepatology. 1995;  21 1031-1037
  CrossrefPubMedGoogle Scholar
• 51 Van de Water J, Turchany J, Leung P S et al.. Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2.  J Clin Invest. 1993;  91 2653-2664
  PubMedGoogle Scholar
• 52 Vallejo A N, Schirmer M, Weyand C M et al.. Clonality and longevity of CD4+CD28null T cells are associated with defects in apoptotic pathways.  J Immunol. 2000;  165 6301-6307
  PubMedGoogle Scholar
• 53 Schmidt D, Goronzy J J, Weyand C M. CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity.  J Clin Invest. 1996;  97 2027-2037
  CrossrefPubMedGoogle Scholar
• 54 Kamihira T, Shimoda S, Harada K et al.. Distinct costimulation dependent and independent autoreactive T-cell clones in primary biliary cirrhosis.  Gastroenterology. 2003;  125 1379-1387
  CrossrefPubMedGoogle Scholar

Hiromi IshibashiM.D. 

Clinical Research Center, National Hospital Organization Nagasaki Medical Center

Omura, Nagasaki 856-8562, Japan

Email: hiishibashi-gi@umin.ac.jp